SB
Sana Biotechnology Inc
🇺🇸XNAS.SANAUnited StatesHealthcare
$3.13USDdown -0.04 (-1.26%)OpenDelayed5:17 PM
Price$3.13-0.04 (-1.26%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US7995661045
- CUSIP
- 799566104
Company
- Employees
- 142
- Headquarters
- Seattle, United States
- Website
- https://www.sana.com
- CEO
- Dr. Steven D. Harr M.D.
Market
- Shares outstanding
- 299.4M
- Market cap
- $937M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $937M
- EPS LTM
- -$0.72
- P/E LTM
- -4.93
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$211.82M+16%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$135.06M+27.11%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.